PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1618289
PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1618289
Digital PCR Market Assessment, By Type, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
Global digital PCR market is projected to witness a CAGR of 9.01% during the forecast period 2025-2032, growing from USD 8.96 billion in 2024 to USD 17.87 billion in 2032. The market demand for digital PCR is anticipated to thrive drastically in the forecast years due to the rise in the prevalence of infectious diseases and cancer driving demand for precise diagnostics, with dPCR offering high sensitivity.
Digital PCR (dPCR) is a highly sensitive and precise technique in molecular biology for detecting and quantifying DNA or RNA. The global digital PCR (dPCR) market is expected to grow significantly due to the increasing demands for accurate and sensitive diagnostic technologies in clinical and research domains. The increasing prevalence of infectious diseases and cancer and growing awareness for personalized medicine further drive the market. Technological advancements, such as enhancements in automation and integration of microfluidics, ensure the efficiency and accessibility of dPCR systems, fostering their adoption. For instance, in June 2024, QIAGEN N.V. introduced 35 new digital PCR microbial DNA detection assays for its QIAcuity platform, enhancing research into infectious diseases. Available on the GeneGlobe platform, the assays detect pathogens responsible for tropical diseases, sexually transmitted infections (STIs), and urinary tract infections (UTIs), expanding QIAGEN's microbial detection portfolio to over 680 targets.
Increasing applications in oncology, detection of infectious diseases, and genetic analysis, combined with increasing investments in genomics research, further growth in the market could be driven by key strategies such as making dPCR systems cost-effective and portable, are strengthening the dynamics in the market.
Increasing Prevalence of Infectious Diseases and Cancer
The growing incidence of infectious diseases and cancer acts as a significant growth driver for the global digital PCR (dPCR) market. The increasing burden of infectious diseases, including COVID-19, HIV, and hepatitis, worldwide increases the demand for highly sensitive and accurate diagnostic tools like dPCR. Low-level pathogen detection and viral load monitoring capability enhance the utility of dPCR in diagnosing and tracking infectious diseases. The rise of cancer cases in the world increases the demand for better diagnostic technologies capable of identifying genetic mutations as well as monitoring minimal residual disease. Thus, its precision in DNA and RNA quantification makes dPCR an essential tool in oncology, propelling the market's expansion. For instance, in November 2024, QIAGEN N.V. launched two new tools for designing and ordering custom solutions for microbial analysis of bacterial, fungal, and viral targets. These tools enable assay customization for both the QIAcuity digital PCR system and third-party NGS systems. Expanding on over 700 existing microbial assays, the tools enhance nanoplate digital PCR for diverse applications, including wastewater testing, food production, and human pathogen analysis, offering high accuracy and precision without the need for a standard curve.
Technological Advancements in Digital PCR
Technological advancements in digital PCR are the major driving factor for the global market, as innovations are constantly improved, enhancing the sensitivity and efficiency of the technology in the process. The newest technologies in automation, microfluidics, and nanotechnology transformed dPCR systems into highly scalable and fast products, thereby reaching an even wider laboratory and health services market. Integrating artificial intelligence (AI) and machine learning into dPCR data analysis further drives its revolution for faster and more precise results. In addition, progress in portability enables devices to be even more compact and user-friendly, expanding the application of dPCR at the point of care. These technological advancements and the low costs of dPCR systems and reagents fuel market growth. For instance, in June 2024, Stilla Technologies SAS expanded its Nio digital PCR line with two new configurations, namely, Nio E (48 samples per run) and Nio (192 samples per run), complementing the flagship Nio+ (384 samples). The Nio family ensures seamless assay transfer across models. Stilla's Nio+, an all-in-one digital PCR instrument, also won the Red Dot Design 2024 award for innovation and design excellence.
Droplet Digital PCR Segment to Dominate Digital PCR Market
The digital PCR market's droplet digital PCR segment will be the highest contributor due to its increased sensitivity and accuracy and the absolute quantification of nucleic acids. It is particularly useful for highly precise detection of low-abundance targets in applications such as oncology, infectious disease diagnostics, and genetic research through partitioning samples into thousands of individual droplets. The increasing adoption of liquid biopsy, minimal residual disease detection, and monitoring of the response to therapies in oncology further add to market domination. Also, this technology is boosted by ongoing advances in droplet generation and detection technology, including user-friendly automated ddPCR platforms, contributing to overall market growth.
For instance, in April 2024, Bio-Rad Laboratories, Inc. launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay for the oncology market. The assay enables simultaneous detection and quantification of seven ESR1 mutations with 0.01% sensitivity. Designed for Bio-Rad's QX600 Droplet Digital PCR System, it supports circulating tumor DNA (ctDNA) and formalin-fixed paraffin-embedded (FFPE) tissue samples, enhancing mutation detection for translational research, therapy selection, and disease monitoring.
North America Dominates the Digital PCR Market
North America dominates the global digital PCR market, holding the largest market share for several significant reasons. Mainly due to its well-developed healthcare infrastructure, advanced research capabilities, and major investments in genomics and molecular diagnostics. The growing incidence of infectious diseases and cancer in North America and the increasing interest in personalized medicine led to a growing demand for precise and sensitive diagnostic tools such as digital PCR. In addition, the widespread adoption of innovative technologies during the initial years and advancement in automation and data analysis in North America also continue to propel the North American digital PCR market. For instance, in March 2024, F. Hoffmann-La Roche AG announced the U.S. Food and Drug Administration (FDA) approval of the cobas Malaria test for use on the cobas 6800/8800 Systems, enhancing blood safety by screening for malaria in blood, organ, and tissue donors. The test provides highly sensitive detection of Plasmodium parasites, helping to remove infected units from the blood supply and improving both safety and availability. This marks the first FDA-approved malaria blood screening test, advancing malaria detection and safeguarding the global blood supply.
Future Market Scenario (2025-2032F)
The future market scenario of the digital PCR (dPCR) market seems to be very promising due to certain technical achievements and the expansion of applications in various industries. The market is expected to experience reliable growth caused by the increase in the demand for accurate, sensitive, and non-invasive diagnostic tools, diseases, and individualized medicine infectious tests in tumors. Integrating artificial intelligence (AI) and machine learning in data analytics and innovations in microfluidics, automation, and portable devices will further enhance the capabilities and accessibility of dPCR technology. Furthermore, increasing adoption of liquid biopsy in cancer diagnostics and increasing use of dPCR in minimal residual disease detection and genetic profiling will drive market expansion.
For instance, in February 2024, Bio-Rad Laboratories, Inc., launched the Vericheck ddPCR Replication Competent Lentivirus Kit and Vericheck ddPCR replication competent adeno-associated virus (AAV) kit, offering rapid, cost-effective solutions for the quantification of replication-competent lentivirus (RCL) and adeno-associated virus (RCAAV). These kits support the safe production of cell and gene therapies by providing highly sensitive and specific detection of viral replication genes, ensuring safety throughout the production process.
Key Players Landscape and Outlook
The global digital PCR market is segmented into instruments, reagents, and services. Major manufacturers lead the instrument segment, while the services segment is fragmented. Recent developments include innovations in automation, product launches, and increased applications in oncology and infectious diseases. Strategic mergers and acquisitions are driving growth.
For instance, in May 2024, QIAGEN announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel digital PCR (dPCR) test for QIAcuity devices, enhancing DNA quantification in forensic samples. The assay will enable simultaneous, absolute quantification of nuclear and mitochondrial DNA, male DNA, and quality markers, improving the accuracy and efficiency of forensic analysis. This advancement, offering higher tolerance to inhibitors and minimal DNA detection, enhances next-generation sequencing (NGS) analysis, especially in challenging samples like aged bones or hair, which is crucial for identifying human remains.
Table of Contents
1. Project Scope and Definitions
2. Research Methodology
3. Executive Summary
4. Global Digital PCR Market Outlook, 2018-2032F
- 4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.2. Market Share Analysis & Forecast
- 4.2.1. By Type
- 4.2.1.1. Droplet Digital PCR
- 4.2.1.2. Chip-based Digital PCR
- 4.2.1.3. Others
- 4.2.2. By Product
- 4.2.2.1. Instruments
- 4.2.2.2. Reagents and Consumables
- 4.2.2.3. Consumables and Services
- 4.2.3. By Application
- 4.2.3.1. Research Applications
- 4.2.3.2. Clinical Applications
- 4.2.3.2.1. Infectious Disease Testing
- 4.2.3.2.2. Oncology Screening
- 4.2.3.2.3. Transplant Testing
- 4.2.3.2.4. Others
- 4.2.3.3. Forensic Applications
- 4.2.3.4. Other Application
- 4.2.4. By End-user
- 4.2.4.1. Hospitals and Clinics
- 4.2.4.2. Pharmaceutical and Biotechnology Industries
- 4.2.4.3. Forensic and Diagnostic Laboratories
- 4.2.4.4. CROs and CDMOs
- 4.2.4.5. Others
- 4.2.5. By Region
- 4.2.5.1. North America
- 4.2.5.2. Europe
- 4.2.5.3. Asia-Pacific
- 4.2.5.4. South America
- 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
- 4.2.1. By Type
- 4.3. Market Map Analysis, 2024
- 4.3.1. By Type
- 4.3.2. By Product
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region
5. North America Digital PCR Market Outlook, 2018-2032F*
- 5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.2. Market Share Analysis & Forecast
- 5.2.1. By Type
- 5.2.1.1. Droplet Digital PCR
- 5.2.1.2. Chip-based Digital PCR
- 5.2.1.3. Others
- 5.2.2. By Product
- 5.2.2.1. Instruments
- 5.2.2.2. Reagents and Consumables
- 5.2.2.3. Consumables and Services
- 5.2.3. By Application
- 5.2.3.1. Research Applications
- 5.2.3.2. Clinical Applications
- 5.2.3.2.1. Infectious Disease Testing
- 5.2.3.2.2. Oncology Screening
- 5.2.3.2.3. Transplant Testing
- 5.2.3.2.4. Others
- 5.2.3.3. Forensic Applications
- 5.2.3.4. Other Application
- 5.2.4. By End-user
- 5.2.4.1. Hospitals and Clinics
- 5.2.4.2. Pharmaceutical and Biotechnology Industries
- 5.2.4.3. Forensic and Diagnostic Laboratories
- 5.2.4.4. CROs and CDMOs
- 5.2.4.5. Others
- 5.2.5. By Country Share
- 5.2.5.1. United States
- 5.2.5.2. Canada
- 5.2.5.3. Mexico
- 5.2.1. By Type
- 5.3. Country Market Assessment
- 5.3.1. United States Digital PCR Market Outlook, 2018-2032F*
- 5.3.1.1. Market Size Analysis & Forecast
- 5.3.1.1.1. By Value
- 5.3.1.2. Market Share Analysis & Forecast
- 5.3.1.2.1. By Type
- 5.3.1.2.1.1. Droplet Digital PCR
- 5.3.1.2.1.2. Chip-based Digital PCR
- 5.3.1.2.1.3. Others
- 5.3.1.2.2. By Product
- 5.3.1.2.2.1. Instruments
- 5.3.1.2.2.2. Reagents and Consumables
- 5.3.1.2.2.3. Consumables and Services
- 5.3.1.2.3. By Application
- 5.3.1.2.3.1. Research Applications
- 5.3.1.2.3.2. Clinical Applications
- 5.3.1.2.3.2.1. Infectious Disease Testing
- 5.3.1.2.3.2.2. Oncology Screening
- 5.3.1.2.3.2.3. Transplant Testing
- 5.3.1.2.3.2.4. Others
- 5.3.1.2.3.3. Forensic Applications
- 5.3.1.2.3.4. Other Application
- 5.3.1.2.4. By End-user
- 5.3.1.2.4.1. Hospitals and Clinics
- 5.3.1.2.4.2. Pharmaceutical and Biotechnology Industries
- 5.3.1.2.4.3. Forensic and Diagnostic Laboratories
- 5.3.1.2.4.4. CROs and CDMOs
- 5.3.1.2.4.5. Others
- 5.3.1.2.1. By Type
- 5.3.1.1. Market Size Analysis & Forecast
- 5.3.2. Canada
- 5.3.3. Mexico
- 5.3.1. United States Digital PCR Market Outlook, 2018-2032F*
All segments will be provided for all regions and countries covered
6. Europe Digital PCR Market Outlook, 2018-2032F
- 6.1. Germany
- 6.2. France
- 6.3. Italy
- 6.4. United Kingdom
- 6.5. Russia
- 6.6. Netherlands
- 6.7. Spain
- 6.8. Poland
7. Asia-Pacific Digital PCR Market Outlook, 2018-2032F
- 7.1. India
- 7.2. China
- 7.3. Japan
- 7.4. Australia
- 7.5. Vietnam
- 7.6. South Korea
- 7.7. Indonesia
- 7.8. Philippines
8. South America Digital PCR Market Outlook, 2018-2032F
- 8.1. Brazil
- 8.2. Argentina
9. Middle East and Africa Digital PCR Market Outlook, 2018-2032F
- 9.1. Saudi Arabia
- 9.2. UAE
- 9.3. South Africa
- 9.4. Israel
10. Demand Supply Analysis
11. Trade Analysis
12. Value Chain Analysis
13. Porter's Five Forces Analysis
14. PESTLE Analysis
15. Pricing Analysis
16. Market Dynamics
- 16.1. Market Drivers
- 16.2. Market Challenges
17. Market Trends and Developments
18. Regulatory Framework and Innovation
- 18.1. Regulatory Approvals
- 18.2. Clinical Trials
19. Patent Landscape
20. Case Studies
21. Competitive Landscape
- 21.1. Competition Matrix of Top 5 Market Leaders
- 21.2. SWOT Analysis for Top 5 Players
- 21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Thermo Fisher Scientific Inc.
- 21.3.1.1. Company Details
- 21.3.1.2. Key Management Personnel
- 21.3.1.3. Products and Services
- 21.3.1.4. Financials (As Reported)
- 21.3.1.5. Key Market Focus and Geographical Presence
- 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 21.3.2. Danaher Corporation
- 21.3.3. QIAGEN N.V.
- 21.3.4. F. Hoffmann-La Roche AG
- 21.3.5. Merck KGaA
- 21.3.6. Precigenome LLC
- 21.3.7. Bio-Rad Laboratories, Inc.
- 21.3.8. Standard BioTools Inc.
- 21.3.9. JN Medsys Pte, Ltd
- 21.3.10. Stilla Technologies SAS
- 21.3.1. Thermo Fisher Scientific Inc.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
22. Strategic Recommendations
23. About Us and Disclaimer
List of Tables
- Table 1. Pricing Analysis of Products from Key Players
- Table 2. Competition Matrix of Top 5 Market Leaders
- Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
- Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
List of Figures
- Figure 1. Global Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 2. Global Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 3. Global Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 4. Global Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 5. Global Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 6. Global Digital PCR Market Share (%), By Region, 2018-2032F
- Figure 7. North America Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 8. North America Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 9. North America Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 10. North America Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 11. North America Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 12. North America Digital PCR Market Share (%), By Country, 2018-2032F
- Figure 13. United States Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 14. United States Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 15. United States Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 16. United States Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 17. United States Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 18. Canada Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 19. Canada Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 20. Canada Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 21. Canada Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 22. Canada Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 23. Mexico Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 24. Mexico Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 25. Mexico Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 26. Mexico Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 27. Mexico Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 28. Europe Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 29. Europe Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 30. Europe Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 31. Europe Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 32. Europe Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 33. Europe Digital PCR Market Share (%), By Country, 2018-2032F
- Figure 34. Germany Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 35. Germany Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 36. Germany Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 37. Germany Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 38. Germany Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 39. France Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 40. France Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 41. France Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 42. France Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 43. France Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 44. Italy Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 45. Italy Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 46. Italy Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 47. Italy Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 48. Italy Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 49. United Kingdom Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 50. United Kingdom Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 51. United Kingdom Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 52. United Kingdom Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 53. United Kingdom Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 54. Russia Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 55. Russia Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 56. Russia Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 57. Russia Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 58. Russia Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 59. Netherlands Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 60. Netherlands Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 61. Netherlands Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 62. Netherlands Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 63. Netherlands Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 64. Spain Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 65. Spain Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 66. Spain Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 67. Spain Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 68. Spain Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 69. Turkey Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 70. Turkey Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 71. Turkey Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 72. Turkey Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 73. Turkey Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 74. Poland Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 75. Poland Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 76. Poland Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 77. Poland Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 78. Poland Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 79. South America Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 80. South America Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 81. South America Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 82. South America Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 83. South America Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 84. South America Digital PCR Market Share (%), By Country, 2018-2032F
- Figure 85. Brazil Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 86. Brazil Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 87. Brazil Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 88. Brazil Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 89. Brazil Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 90. Argentina Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 91. Argentina Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 92. Argentina Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 93. Argentina Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 94. Argentina Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 95. Asia-Pacific Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 96. Asia-Pacific Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 97. Asia-Pacific Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 98. Asia-Pacific Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 99. Asia-Pacific Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 100. Asia-Pacific Digital PCR Market Share (%), By Country, 2018-2032F
- Figure 101. India Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 102. India Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 103. India Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 104. India Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 105. India Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 106. China Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 107. China Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 108. China Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 109. China Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 110. China Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 111. Japan Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 112. Japan Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 113. Japan Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 114. Japan Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 115. Japan Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 116. Australia Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 117. Australia Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 118. Australia Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 119. Australia Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 120. Australia Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 121. Vietnam Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 122. Vietnam Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 123. Vietnam Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 124. Vietnam Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 125. Vietnam Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 126. South Korea Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 127. South Korea Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 128. South Korea Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 129. South Korea Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 130. South Korea Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 131. Indonesia Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 132. Indonesia Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 133. Indonesia Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 134. Indonesia Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 135. Indonesia Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 136. Philippines Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 137. Philippines Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 138. Philippines Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 139. Philippines Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 140. Philippines Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 141. Middle East & Africa Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 142. Middle East & Africa Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 143. Middle East & Africa Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 144. Middle East & Africa Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 145. Middle East & Africa Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 146. Middle East & Africa Digital PCR Market Share (%), By Country, 2018-2032F
- Figure 147. Saudi Arabia Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 148. Saudi Arabia Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 149. Saudi Arabia Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 150. Saudi Arabia Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 151. Saudi Arabia Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 152. UAE Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 153. UAE Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 154. UAE Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 155. UAE Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 156. UAE Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 157. South Africa Digital PCR Market, By Value, In USD Billion, 2018-2032F
- Figure 158. South Africa Digital PCR Market Share (%), By Type, 2018-2032F
- Figure 159. South Africa Digital PCR Market Share (%), By Product, 2018-2032F
- Figure 160. South Africa Digital PCR Market Share (%), By Application, 2018-2032F
- Figure 161. South Africa Digital PCR Market Share (%), By End-user, 2018-2032F
- Figure 162. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 163. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
- Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
